Patient‐reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials

Documenti analoghi

• Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer
  di: Natansh D. Modi, et al.
  Pubblicazione: (2025)
• Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma
  di: Ahmad Y. Abuhelwa, et al.
  Pubblicazione: (2025)
• Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial
  di: Yuan Gao, et al.
  Pubblicazione: (2025)
• Treatment‐Specific Prediction Models in Multiple Myeloma: A Critical Review of Current Evidence and Future Directions
  di: Mays M. Jarrah, et al.
  Pubblicazione: (2026)
• Behavior of the Position and Ellipticity Angles at Polarization Mode Transitions in Pulsar Radio Emission
  di: McKinnon, M. M.
  Pubblicazione: (2024)